EIF4EBP1 and Alzheimer disease: Our findings showed that LGZG can significantly modulate the expression of autophagy-related proteins by inhibiting the mTOR signaling pathway, reducing p-mTOR and p70S6K levels while increasing 4EBP1, suggesting its potential therapeutic effect on AD.